- Home
- NSSC vs COGT Comparison
NSSC vs COGT Comparison
Compare NSSC & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSSC
- COGT
- Stock Information
- Founded
- NSSC 1969
- COGT 2014
- Country
- NSSC United States
- COGT United States
- Employees
- NSSC N/A
- COGT N/A
- Industry
- NSSC Telecommunications Equipment
- COGT Biotechnology: Pharmaceutical Preparations
- Sector
- NSSC Telecommunications
- COGT Health Care
- Exchange
- NSSC Nasdaq
- COGT Nasdaq
- Market Cap
- NSSC 1.1B
- COGT 1.1B
- IPO Year
- NSSC N/A
- COGT 2018
- Fundamental
- Price
- NSSC $41.85
- COGT $12.46
- Analyst Decision
- NSSC Strong Buy
- COGT Strong Buy
- Analyst Count
- NSSC 6
- COGT 11
- Target Price
- NSSC $37.67
- COGT $21.20
- AVG Volume (30 Days)
- NSSC 515.0K
- COGT 1.5M
- Earning Date
- NSSC 11-03-2025
- COGT 11-11-2025
- Dividend Yield
- NSSC 1.30%
- COGT N/A
- EPS Growth
- NSSC N/A
- COGT N/A
- EPS
- NSSC 1.19
- COGT N/A
- Revenue
- NSSC $181,621,000.00
- COGT N/A
- Revenue This Year
- NSSC $5.13
- COGT N/A
- Revenue Next Year
- NSSC $11.41
- COGT N/A
- P/E Ratio
- NSSC $36.08
- COGT N/A
- Revenue Growth
- NSSC N/A
- COGT N/A
- 52 Week Low
- NSSC $19.00
- COGT $3.72
- 52 Week High
- NSSC $44.24
- COGT $13.50
- Technical
- Relative Strength Index (RSI)
- NSSC 69.13
- COGT 53.76
- Support Level
- NSSC $39.81
- COGT $12.31
- Resistance Level
- NSSC $44.24
- COGT $12.86
- Average True Range (ATR)
- NSSC 1.23
- COGT 0.49
- MACD
- NSSC 0.09
- COGT -0.09
- Stochastic Oscillator
- NSSC 61.72
- COGT 34.36
About NSSC NAPCO Security Technologies Inc.
NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.